SUBMIT BOOK PROPOSAL
Online Store
benthambooks logo

Site Breadcrumb

Advances in Cancer Drug Targets
View Sample

Editor: Atta-ur-Rahman

Advances in Cancer Drug Targets

Volume 2
eBook: US $89 Special Offer (PDF + Printed Copy): US $176
Printed Copy: US $131
Library License: US $356
ISSN: 2451-8891 (Print)
ISSN: 2213-9915 (Online)
ISBN: 978-1-60805-939-3 (Print)
ISBN: 978-1-60805-938-6 (Online)
Year of Publication: 2014
DOI: 10.2174/97816080593861140201
Rate This Book

Introduction

Advances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA.

The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development.

The contents of this book include chapters on heat shock protein 90, spindle assembly checkpoint, ErbB receptors, anti-tumor effects of bisphosphonates, biomarkers for risk assessment and prevention of breast cancer, fibrates action in Daunorubicin chemical reaction and many more.

The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists.

Indexed in: EBSCO.


eBook: US $89 Special Offer: US $176 Printed Copy: US $131 Library License: US $356

Contributors

Editor(s):
Atta-ur-Rahman
Kings College, University of Cambridge
Honorary Life Fellow
Cambridge
UK



Contributor(s):
A. Brenner
Department of Clinical Science
University of Bergen
Bergen
Norway


Adriano Angelucci
Department of Biotechnological and Applied Clinical Sciences
University of L’Aquila
L’Aquila
Italy


Alberto Luini
Division of Breast Surgery
European Institute of Oncology
Milan
Italy


Andrea Bonetto
Department of Surgery
Indiana University School of Medicine
Indianapolis
IUPUI, IN
USA


Andrea Decensi
Medical Oncology
E.O. Ospedali Galliera
Genoa
Italy


Baoguang Hu
Department of Surgery, Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong
China
/
Department of Gastrointestinal Surgery
The Affiliated Hospital of Binzhou Medical University
Binzhou, Shandong
China


Bernardo Bonanni
Division of Cancer Prevention and Genetics
European Institute of Oncology
Milan
Italy


E. Ersvær
Department of Clinical Science
University of Bergen
Bergen
Norway


Fabio Penna
Department of Clinical and Biological Sciences
University of Turin
Italy
/
Interuniversitary Institute of Myology
Italy


Francesco M. Baccino
Department of Clinical and Biological Sciences
University of Turin
Italy


Gabriella Bonelli
Department of Clinical and Biological Sciences
University of Turin
Italy


Ganesaratnam K. Balendiran
Department of Chemistry
Youngstown State University
One University Plaza
Youngstown
OH, 44555
USA


Gang Song
Department of Surgery, Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong
China
/
Cancer Research Center
Medical College of Xiamen University
Xiamen
People's Republic of China


George G. Chen
Department of Surgery
Faculty of Medicine, The Chinese University of Hong Kong
Hong Kong
China


H. Reikvam
Department of Clinical Science
University of Bergen
Bergen
Norway
/
Department of Medicine
Haukeland University Hospital
Bergen
Norway


Hannah K. Brown
Academic Unit of Clinical Oncology
University of Sheffield
Sheffield
UK


Ingunn Holen
Academic Unit of Clinical Oncology
University of Sheffield
Sheffield
UK


K.J. Hatfield
Department of Clinical Science
University of Bergen
Bergen
Norway


Kathrin Barth
Institute of Anatomy, Medical Faculty “Carl Gustav Carus”
Technische Universität Dresden
01307 Dresden
Germany


Liping Liu
Department of Surgery, Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong
China
/
Department of Hepatobiliary and Pancreas Department of Hepatobiliary Surgery
The Second Clinical Medical College of Jinan University (Shenzhen People's Hospital)
Shenzhen
Guangdong Province
China


Maria Kapanidou
Faculty of Health and Life Sciences
Department of Biological and Medical Sciences; Oxford Brookes University
Oxford
England, OX3 0BP, UK


Massimiliano Cazzaniga
Division of Cancer Prevention and Genetics
European Institute of Oncology
Milan
Italy


Michael Kasper
Institute of Anatomy, Medical Faculty “Carl Gustav Carus”
Technische Universität Dresden
Dresden, 01307
Germany


Ø. Bruserud
Department of Clinical Science
University of Bergen
Bergen
Norway
/
Department of Medicine
Haukeland University Hospital
Bergen
Norway


Oreste Gentilini
Division of Breast Surgery
European Institute of Oncology
Milan
Italy


Paola Costelli
Department of Clinical and Biological Sciences
University of Turin
Italy
/
Interuniversitary Institute of Myology
Italy


Paul B.S. Lai
Department of Surgery, Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong
China


Peggy A. Scherle
Incyte Corporation
Wilmington
DE, 19880
USA


R.B. Forthun
Department of Clinical Science
University of Bergen
Bergen
Norway


Robert C. Newton
Incyte Corporation
Wilmington
DE, 19880
USA


Steven M. Friedman
Incyte Corporation
Wilmington
DE, 19880
USA


Victor M. Bolanos-Garcia
Faculty of Health and Life Sciences
Department of Biological and Medical Sciences; Oxford Brookes University
Oxford
England, OX3 0BP, UK


Xiangdong Liu
Incyte Corporation
Wilmington
DE, 19880
USA